E-DRUG: South African court case on MTCT/Nevirapine
--------------------------------------------------------------------
[TAC and Dept of Health were on the same side in April, against the drug
companies.
However, TAC has now taken DOH to court as they want more access in South
Africa's
public sector to nevirapine.
Nevirapine was offered free of charge by Boehringer Ingelheim for 5 years.
TAC is at: http://www.tac.org.za
The DOH position is at: http://www.doh.gov.za/
For a review of the WHO position on nevirapine use in MTCT, go to:
http://www.who.int/reproductive-health/rtis/MTCT/index.htm
and for a technical report to:
http://www.who.int/HIV_AIDS/MTCT/index.htm
NN]
19th November 2001
Dear Friends
GIVE WOMEN A CHOICE! GIVE CHILDREN A CHANCE!
TAC APPEALS FOR GLOBAL SOLIDARITY IN MOTHER-TO-CHILD-
TRANSMISSION (MTCT) COURT CASE
On the 26-27 November 2001, South Africa will witness a court case that
can help to alter the course of the HIV/AIDS epidemic in our country. The
Treatment Action Campaign (TAC) calls on your support and solidarity to
save people from unnecessary death and suffering. We ask you to
encourage our government to change its tragic course in the HIV/AIDS
epidemic. At heart, this court case is about giving women a choice and
children a chance.
Across our country nearly 300 000 women with HIV will give birth this year.
The majority do not know their HIV status and are not given information or
medicine that can reduce the risk of HIV transmission to their children. As
a consequence, at least 70 000 children will be infected with HIV during
labour and through breastfeeding. They will suffer an unnecessary painful
death.
The government has the resources and the opportunity to give women a
choice to look after their own health and a chance to prevent their infants
from becoming infected with HIV. But, it has dithered and reacted
unscientifically, unlawfully and with no morality to calls for the
implementation of MTCT prevention programmes.
For more than five years civil society, initially led by the AIDS Law
Project
and the AIDS Consortium, have lobbied government to implement MTCT
programmes to reduce HIV transmission to infants. Since December 1998,
TAC has led the call for government to take action. We have petitioned,
negotiated, written appeals, organised workshops and conferences,
publicised the need for government action -- all to no avail.
In March 2000, Judge Edwin Cameron made the following appeal to the
government in the presence of the Minister of Health at a national
conference of people living with HIV/AIDS:
"Since 1994, very detailed and careful scientific and medical studies have
been done on how to reduce the risk that a mother with HIV will transmit it
to her baby during or after birth. The overwhelming scientific consensus is
that effective anti-retroviral medication can be made available in a
developing country to reduce transmission. Every month in our country,
approximately five thousand babies are born with HIV. Medicines exist
that, now, can reduce this figure by half. Economists have done detailed
studies that show that this medication can be made available cheaply and
affordably. Their studies have also shown that, from a purely economic
point of view, it is better to save young babies from getting HIV than to
let
them fall sick and die of AIDS, and that intervention will save the country
money.
"So overwhelming is the medical, scientific and economic consensus on
these points, that many people find it almost impossible to understand why
our Government is still delaying the immediate implementation of programs
to prevent mother to child transmission of HIV. If government commits
itself to helping pregnant mothers, it will throw a beam of hope onto the
entire epidemic. It will throw a beam of light onto all our lives. If babies
can
be protected from exposure to HIV by giving medicine to their mothers,
then all of us can hope that progressive implementation of an accessible
drugs programme will save many more lives in South Africa and in our
continent as a whole."
The government has spurned every opportunity to do the right thing.
Despite the TAC's unshakeable support for the government during its court
battle with the drug companies, TAC has had no option but to defend the
rights of poor women with HIV and children against the government.
For TAC, legal proceedings were our last resort - they give people who have
lost faith in the government's commitment to address all aspects of the
HIV/AIDS epidemic a legitimate and legal avenue to defend their
constitutional rights to healthcare access, life, dignity and equality. We
are not opposed to our government. We are opposed to the misguided and
unconstitutional actions (or lack of them) on HIV/AIDS prevention and
treatment. You can consult our court papers at www.tac.org.za
In August, we appealed publicly to the Government to abandon its
opposition to the orders TAC is seeking from the court: access to
Nevirapine for women and children who need it (under proper medical
supervision), and a clear national programme to prevent mother to child HIV
transmission. The Minister of Health spurned this appeal.
We therefore appeal to every person in South Africa and across the globe
to support TAC's court action. We urge you to write letters of support to
TAC at the following address: TAC National Office Town One Properties,
Sulani Drive, Site B, Khayelitsha. Tel: +27 (0)21-364 5609 Fax: +27 (0)21
364 6653 Email: info@tac.org.za
Where possible, TAC requests supporters in South Africa to attend the
hearing in court or to join demonstrations. We request that international
allies arrange meetings with the South African Embassies to urge the
South African government to settle the court case.
Please do not hesitate to make further enquiries.
Yours sincerely
Siphokazi Mthathi (TAC); Email: info@tac.org.za
Cati Vawda (Children's Rights Centre)
Dr. Haroon Saloojee (Save Our Babies)
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: owner-e-drug@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html